Patents
Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320)
11/2013
11/07/2013WO2012145469A8 Human monoclonal antibodies specific for glypican-3 and use thereof
11/07/2013WO2012140620A8 Compositions for preventing and/or treating an infection by an hiv-1 virus
11/07/2013WO2012122378A3 Antibody-like proteins for therapeutic and diagnostic use
11/07/2013WO2002101075A9 Novel genes, compositions, kits, and methods for identification, assessment, prevention, and therapy of cervical cancer
11/07/2013WO2002083860A9 Nucleic acid and corresponding protein entitled 151p3d4 useful in treatment and detection of cancer
11/07/2013US20130296537 Methamphetamine-like hapten compounds, linkers, carriers and compositions and uses thereof
11/07/2013US20130296536 Notch binding agents and antagonists and methods of use thereof
11/07/2013US20130296249 Methods of blocking tissue destruction by autoreactive t cells
11/07/2013US20130296240 Pneumonia biomarkers
11/07/2013US20130295613 Animal cell culturing method
11/07/2013US20130295612 Anti-glypican-3 antibody having improved kinetics in plasma
11/07/2013US20130295611 Humanized antibody molecules specific for il-31
11/07/2013US20130295610 Chimeric antigens for eliciting an immune response
11/07/2013US20130295125 Compositions and methods relating to mouse papilloma virus
11/07/2013US20130295120 Vaccines based on targeting antigen to dcir expressed on antigen-presenting cells
11/07/2013US20130295119 Folate Receptor 1 Antibodies and Immunoconjugates and Uses Thereof
11/07/2013US20130295118 Antibodies specific for cll-1
11/07/2013US20130295116 Therapeutic antibodies
11/07/2013US20130295113 Anti-erythropoietin antibodies
11/07/2013US20130295112 Antibodies Against Nerve Growth Factor (NGF) With Enhanced In Vivo Stability
11/07/2013US20130295109 Uses of antibodies
11/07/2013US20130295108 Method for treating synovial sarcoma
11/07/2013US20130295107 Antibody to human il-3 receptor alpha chain
11/07/2013US20130295106 Frizzled-Binding Agents And Uses Thereof
11/07/2013US20130295105 Frizzled-binding agents and uses thereof
11/07/2013US20130295104 CD37-Binding Molecules and Immunoconjugates Thereof
11/07/2013US20130295103 Antibodies against a proliferating inducing ligand (april)
11/07/2013US20130295102 Compositions and methods for antibodies targeting factor p
11/07/2013US20130295101 Ricin Vaccine and Methods of Making Thereof
11/07/2013US20130295099 N-linkedglycan compounds
11/07/2013US20130295098 Multispecific epitope binding proteins and uses thereof
11/07/2013US20130295097 Human Antibodies to Fel d1 and Methods of Use Thereof
11/07/2013US20130295096 Degraded agonist antibody
11/07/2013US20130295095 Monoclonal antibodies targeting amyloid beta oligomers
11/07/2013US20130295090 Humanized monoclonal antibodies that specifically bind and/or neutralize japanese encephalitis virus (jev) and their use
11/07/2013US20130295086 Antibodies selective for cells presenting egfr at high density
11/07/2013US20130295085 ANTI-CD154 ANTIBODIES HAVING IMPAIRED FcR BINDING AND/OR COMPLEMENT BINDING PROPERTIES AND USE IN THERAPY
11/07/2013US20130295084 Binding proteins having tethered light chains
11/07/2013US20130295050 Anti-igf-i receptor antibodies, dnas, vectors, host cells and genetic constructs
11/07/2013US20130295045 Medicament comprising recombinant antibody against chemokine receptor ccr4
11/07/2013US20130295021 Human anti-tau antibodies
11/07/2013US20130295007 Anti-pmel17 antibodies and immunoconjugates
11/07/2013US20130295004 Il-1 binding proteins
11/07/2013CA2871985A1 Anti-il-23p19 antibodies
11/06/2013EP2660600A1 Diagnostic drug and diagnostic method for alzheimer's disease
11/06/2013EP2660592A2 Method for selecting cereal seeds suitable for consumption by coeliac patients
11/06/2013EP2660251A1 Antibodies or fragments thereof against hemopexin for use in the treatment of ocular diseases
11/06/2013EP2659893A2 T cell regulation
11/06/2013EP2659275A2 Detection of a polypeptide dimer by a bivalent binding agent
11/06/2013EP2659273A1 Monoclonal antibodies against alpha-actinin-4 antigens, and uses therefor
11/06/2013EP2659270A2 Comprehensive monoclonal antibody generation
11/06/2013EP2658970A2 Express humanization of antibodies
11/06/2013EP2658873A2 A cross-linking polypeptide that induces apoptosis
11/06/2013EP2658872A1 A polypeptide that binds aberrant cells and induces apoptosis
11/06/2013EP2658871A1 Anti-cd38 antibodies
11/06/2013EP2658870A1 Conjugated anti-cd38 antibodies
11/06/2013EP2658869A1 Antigen binding formats for use in therapeutic treatments or diagnostic assays
11/06/2013EP2658868A1 Her3 protein srm/mrm assay
11/06/2013EP2658575A1 Pharmaceutical formulation comprising a biopharmaceutical drug
11/06/2013EP2359853B1 Pharmaceutical compositions and methods useful for modulating angiogenesis
11/06/2013CN103384831A Detection of a polypeptide dimer by a bivalent binding agent
11/06/2013CN103384682A Antibody molecules which bind IL-17A and IL-17F
11/06/2013CN103384681A Binding agent
11/06/2013CN103384530A Breast cancer therapeutics
11/06/2013CN103382459A Hybridoma cell strain, anti-streptomycin monoclonal antibody produced by same and application
11/06/2013CN103382224A Heterologous cross-linking object containing heterologous cross-linking antibody in tetramer form and applications thereof
11/06/2013CN103382223A Multi-functional antibody polypeptide aiming at epidermal growth factor receptor (EGFR) cryptic epitope and T cell antigen
11/06/2013CN103382222A Alpha-4-beta-7 heterodimer specific antagonist antibody
11/06/2013CN103382221A Single chain antibody 19B7 for specific recognition and neutralization of grass carp reovirus
11/06/2013CN103382220A Cell factor FAM19A4 with anti-infection and antineoplastic activity and application thereof
11/06/2013CN103381274A Genetic products differentially expressed in tumors and the use thereof
11/06/2013CN103380941A Biological fresh-keeping agent for inhibiting blackening of Litopenaeus vannamei bodies
11/06/2013CN102786597B Anti ERCC1 monoclonal antibody 2E12 and application
11/06/2013CN102690788B Zearalenone anti-idiotypic antibody, preparation method thereof, and application thereof
11/06/2013CN102659922B Peptide Derived From Hepatitis C Virus
11/06/2013CN102653561B Single-chain antibody and application thereof in detecting beta-stimulant
11/06/2013CN102459603B Fucosylation-deficient cells
11/06/2013CN102206275B Anti-tetanotoxin monoclonal neutral antibody, and composition and application thereof
11/06/2013CN101918555B Humanized anti-alpha9 integrin antibodies and the uses thereof
11/06/2013CN101855241B Monoclonal antibodies against ANGPTL3
11/06/2013CN101835892B CDCA1 peptide and pharmaceutical agent comprising the same
11/06/2013CN101798586B Process for producing glycopeptides
11/06/2013CN101679528B Apoptotic anti-IGE antibodies
11/06/2013CN101679523B Novel fully human anti-vap-1 monoclonal antibodies
11/06/2013CN101657467B Human cytomegalovirus neutralising antibodies and use thereof
11/06/2013CN101628111B Taci-immunoglobulin fusion proteins
11/06/2013CN101622275B Method of providing disease-specific binding molecules and targets
11/06/2013CN101506238B Methods and compositions with enhanced therapeutic activity
11/06/2013CN101490087B Antibodies and immunoconjugates and uses therefor
11/06/2013CN101484471B Anti-NKG2A antibodies and uses thereof
11/06/2013CN101466736B Therapy targeting cathepsin S
11/06/2013CN101302515B Human antibodies that bind human TNF(alpha)
11/06/2013CN101189334B 抗cd14抗体融合蛋白质 Anti-cd14 antibody fusion proteins
11/06/2013CN101073667B Enhancer for antibody to lymphocytic tumors
11/05/2013US8575319 Cleavable vaccine compositions and uses thereof and methods of making and using the same
11/05/2013US8575318 Hepatocyte growth factor (HGF) binding proteins
11/05/2013US8575317 Anti-NR10 antibody and use thereof
11/05/2013US8575316 Anti-Siglec-15 antibody
11/05/2013US8575315 Immunizing compositions and methods of use
11/05/2013US8575314 Antibody against oxidized LDL/β2GPI complex and use of the same
1 ... 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 ... 1494